Overzicht Proefschriften
Tips in using the search/filter fieldsDisplaying 101-150 of 278 results.
Titel | Promovendus | Promotor 1 | Promotor 2 | Copromotor 1 | Copromotor 2 | Universiteit | Promotiejaar | Trefwoorden |
---|---|---|---|---|---|---|---|---|
Mitochondrial failure in sepsis; Acute mechnisms and long-term consequences. | Henning R.H., prof. dr. | Bouma H.R., PhD | Rijksuniversiteit Groningen (RUG) | 0 | Mitrochondrial failure in Sepsis | |||
Peripheral Projections of the Trigeminovascular System as Antimigraine Target | Labastida Ramírez A | Danser A.H.J., prof. dr. | Maassen van den Brink A., dr. | Erasmus Universiteit Rotterdam (EUR) | 2019 | Migraine; Vascular reactivity; Pharmacology; | ||
Vascular Effects of Current and Novel Antimigraine Drugs | Rubio Beltrán AE | Danser A.H.J., prof. dr. | Maassen van den Brink A., dr. | Erasmus Universiteit Rotterdam (EUR) | 2019 | Migraine; Vascular reactivity; Drug efficacy; Pharmacology; | ||
Microvasculature, the Trigeminal System and Migraine: A focus on female sex hormones | Ibrahimi K., PhD | Danser A.H.J., prof. dr. | Maassen van den Brink A., dr. | Meiracker A.H. van den, dr. | Erasmus Universiteit Rotterdam (EUR) | 2015 | Migraine; Microvasculature; Trigeminal System; Female Sex Hormones | |
Intranasal drug delivery in migraine | Kuy P.H.M. van der, dr. | Merkus F.W.H.M., prof. dr. | Lohman J.J.H.M., dr. | Universiteit Leiden (UL) | 2003 | Migraine; Intranasal | ||
Clinical manifestations of sex hormonal influences in migraine | Casteren D.S. van, PhD | Danser A.H.J., prof. dr. | Terwindt G.M., prof. dr. | Maassen van den Brink A., dr. | Universiteit Leiden (UL) | 2021 | Migraine; Clinical pharmacology; Treatment; Endocrinology; Pharmacology; | |
Methodological approaches to the pharmacogenomics of statins | Peters B.J.M., dr. | Boer A. de, prof. dr. | Maitland-van der Zee A.H., prof. dr. | Klungel O.H., prof. dr. | Universiteit Utrecht (UU) | 2010 | Methodology; Statins; Pharmacogenomics; | |
Harmonising relative effectiveness assessments of medicines in Europe | Kleijnen S., PhD | Boer A. de, prof. dr. | Leufkens H.G.M., prof. dr. | Goettsch W.G., dr. | Universiteit Utrecht (UU) | 2016 | Medicines; Relative effectiveness; Reimbursement; Harmonisation; Europe; Methods; Health technology assessment (HTA); | |
Sustainable use of medication : medication waste and feasibility of redispensing | Bekker C.L., PhD | Egberts A.C.G., prof. dr. | Bouvy M.L., prof. dr. | Bemt B.J.F. van den, dr. | Gardarsdottir H., dr. | Universiteit Utrecht (UU) | 2018 | Medication waste; UGT2B7; Unused medication; Redispensing; Pharmacy practice; Cost-benefit ratio; |
Medication safety through information technology; a focus on medication prescribing and administering. | Helmons P.J., PhD | Kosterink J.G.W., prof. dr. | Daniels C.E., prof. dr. | Rijksuniversiteit Groningen (RUG) | 2014 | medication safety information technology prescribing and administering drugs | ||
Supporting patients : pharmacy based interventions to improve medication adherence | Kooij M.J., PhD | Bouvy M.L., prof. dr. | Heerdink E.R., dr. | Dijk C.E.M.J. van, dr. ir. | Universiteit Utrecht (UU) | 2015 | Medication adherence; Pharmacists; Intervention; Pharmacy; Compliance; Community pharmacy; | |
Lithium in older patients : treatment patterns and somatic adverse effects | Melick E.J.M. van, PhD | Egberts A.C.G., prof. dr. | Wilting I., dr. | Universiteit Utrecht (UU) | 2014 | Lithium; Older patients; Pharmacodynamics; Pharmacokinetics; Antidepressants; | ||
Clinical pharmacology and bioanalysis of antileishmanial drugs : Towards improved treatment strategies for leishmaniasis | Kip A.E., PhD | Beijnen J.H., prof. dr. | Schellens J.H.M., prof. dr. | Dorlo T.P.C., dr. | Universiteit Utrecht (UU) | 2017 | Leishmaniasis; Clinical pharmacology; Bioanalysis; Pharmacokinetics; Pharmacodynamics; Miltefosine; Amphotericin B; Neopterin; | |
Individualized dosing of calcineurin inhibitors in renal transplantation | Press R.R., PhD | Guchelaar H.J., prof. dr. | Fijter J.W. de, prof. dr. | Ploeger B.A., dr. | Universiteit Leiden (UL) | 2011 | Kidney; Transplantation; Calcineurin inhibitors; | |
The association between albuminuria and long-term renal risk; how to improve the precision of drug effect estimates | Kröpelin T.F., PhD | Zeeuw D. de, prof. dr. | Lambers Heerspink H.J., prof. dr. | Rijksuniversiteit Groningen (RUG) | 2016 | Kidney; Diabetic kidney disease; Drug efficacy; | ||
Isoflurane induced eNOS signaling and cardioprotection: preconditioning mechanisms under normal and hyperglycemic conditions | Baotic I., PhD | Henning R.H., prof. dr. | Epema A.H., dr. | Rijksuniversiteit Groningen (RUG) | 2018 | Isoflurane; eNOS; cardioprotection | ||
Pharmacological modulation of ischemia and reperfusion injury | Meijer P., PhD | Rongen G.A., prof. dr. | Smits P., prof. dr. | Radboud Universiteit (RU) | 2012 | Ischemia/Reperfusion injury; rosuvastatin; adenosine; forearm; | ||
Assessment of ischaemia and reperfusion injury | Wouters C.W., PhD | Rongen G.A., prof. dr. | Oyen W.J.G., prof. dr. | Radboud Universiteit (RU) | 2013 | Ischemia/reperfusion injury; adenosine; atorvastatin; forearm; | ||
Intranasal delivery of rapid acting drugs | Veldhorst-Janssen N.M.L., PhD | Marcus A.E., prof. dr. | Neef C., prof. dr. | Kuy P.H.M. van der, dr. | Universiteit Maastricht (UM) | 2013 | Intranasal; fentanyl; midazolam | |
Psychotropic drug use in people with intellectual disability: patterns of use and critical evaluation : patterns of use and critical evaluation | Scheifes A., PhD | Egberts A.C.G., prof. dr. | Nijman H.L.I., prof. dr. | Heerdink E.R., dr. | Stolker J.J., dr. | Universiteit Utrecht (UU) | 2015 | Intellectual disability; dis; Psychotropic drugs; Pharmacoepidemiology; Prevalence; Adverse events; Medication reviews; |
Physical causes of dosing errors in patients receiving multi-infusion therapy | Snijder R.A., PhD | Egberts A.C.G., prof. dr. | Timmerman A.M.D.E., dr. ir. | Konings M.K., dr. | Universiteit Utrecht (UU) | 2016 | Infusion; Multi-infusion; Patient safety; Fluid mechanics; Physics; Modeling errors; Adverse events; | |
Immunological aspects of conventional and new treatments for cervical cancer, an immunopharmacological approach | Meir H. van | Burg S.H van der, Prof.dr. | Burggraaf J., prof. dr. | Kalkman C.J., prof. dr. | Peeters M.Y.M., dr. | 2017 | Immunotherapy Combined chemo-immunotherapy Cervical cancer HPV16-SLP vaccination Immunomonitoring | |
Clinical pharmacology of immuno-modulatory biotherapeutics : innovations in early drug development | Dillingh M.R., PhD | Burggraaf J., prof. dr. | Cohen A.F., prof. dr. | Moerland M., dr. | Universiteit Leiden (UL) | 2017 | Immuno-modulatory biotherapeutics; Drug development; | |
Fluorescence-guided cancer surgery:clinical translation of tumor targeted agents | Hoogstins C.E.S | Burggraaf J., prof. dr. | Cohen A.F., prof. dr. | Vahrmeijer A.L., Dr. | Universiteit Leiden (UL) | 2018 | Image-guided surgery Fluorescence Tumor targeted Oncological surgery | |
Reversible suppression of hemostasis in hibernation and hypothermia | Vrij E.L. de | Henning R.H., prof. dr. | Bouma H.R., PhD | Rijksuniversiteit Groningen (RUG) | 2019 | Hypothermia; Hibernation; | ||
Hypertension and renal toxicity during angiogenesis inhibition: Salt dependency and treatment options | Lankhorst S. | Danser A.H.J., prof. dr. | Meiracker A.H. van den, dr. | Kappers M.H.W., PhD | Erasmus Universiteit Rotterdam (EUR) | 2016 | Hypertension; Renal function; Treatment options | |
Unintended effects of anti-hyperglycaemic drugs studied in population-based cohorts | Driessen J.H.M., PhD | Bergh J.P.W. van den, prof. dr. | Vries F. de, prof. dr. | Onzenoort H.A.W. van, PhD | Universiteit Maastricht (UM) | 2017 | Hyperglycaemic drugs; Population-based; | |
Cognition in Huntington's disease : the influence of motor behaviour and time | Hart E.P. 't, PhD | Roos R.A.C., prof. dr. | Universiteit Leiden (UL) | 2013 | Huntington's disease; Cognition; Movement disorder; Executive functioning; Memory; P300; Motor behaviour | |||
Early phase clinical drug development for HPV-induced disorders: novel tools and treatments | Rijsbergen M. | Burggraaf J., prof. dr. | Rissmann R, prof.dr. | Poelgeest M.I.E. van, dr. | Universiteit Leiden (UL) | 2020 | HPV-induced diseases; | |
Optmizing long-term care for hiv-infected patients in Thailand | Ramautarsing R.A., PhD | Burger D.M., prof. dr. | Wit F.W.N.M., dr. | Wijgert J.H.H.M. van de, dr. | Universiteit van Amsterdam (UvA) | 2013 | HIV; clinical pharmacology | |
Exposure to antiretroviral agents in hiv-infected pregnant women: not too much-not too little | Colbers E.P.H., PhD | Burger D.M., prof. dr. | Radboud Universiteit (RU) | 2015 | HIV; antiretroviral agents; clinical pharmacology; drug drug interactions | |||
Modulation of endogenous H2S productin: its role in hibernation and pharmacological cell protection | Talaei F., PhD | Henning R.H., prof. dr. | Schmidt M., prof. dr. | Rijksuniversiteit Groningen (RUG) | 2012 | Hibernation; Endogenous H2S production; Pharmacological cell protection; Hypothermia; Cysteinyldopa; | ||
Immunological aspects of hibernation as leads in the prevention of acute organ injury. | Bouma H.R., PhD | Henning R.H., prof. dr. | Kroese F.G.M., prof. dr. | Strijkstra A.M., dr. | Rijksuniversiteit Groningen (RUG) | 2013 | hibernation acute organ injury immunological | |
Hibernating mitochondria, the cool key to cellular protection and transplant optimization; Mitochondrial aspects of hibernators and non-hibernators in hypothermia | Hendriks K.D.W. | Henning R.H., prof. dr. | Leuverink H.G.D., prof. dr. | Rijksuniversiteit Groningen (RUG) | 2021 | Hibernating mitochondria | ||
Introducing Clinical Pharmacology to Hepatitis C Therapy | Kanter C.T.M.M. de, PhD | Burger D.M., prof. dr. | Drenth J.P.H., prof. dr. | Dofferhoff A.S.M., dr. | Radboud Universiteit (RU) | 2015 | Hepatitis C; Clinical Pharmacology; Therapeutic drug monitoring; drug drug interactions | |
Clinical risk management of drug-related hospital admissions: strategies for their identification, reduction and monitoring | Warlé-van Herwaarden M., PhD | Smet P.A.G.M. de, prof. dr. | Sturkenboom M.C.J.M., prof. dr. | Kramers C., dr. | Herings R.M.C., dr. | Radboud Universiteit (RU) | 2015 | Guideline adherence; medication safety; laboratory monitoring |
Exploring the role of glucagon in glucose homeostasis | Dongen M.G.J. van, PhD | Cohen A.F., prof. dr. | Romijn J.A., prof dr | Burggraaf J., prof. dr. | Universiteit Leiden (UL) | 2015 | Glucagon; Diabetes mellitus; Glucose homeostasis; Glucagon challenge; Glucagon receptor antagonist; Insulin | |
Mounting an attack on the glioblastoma triad : proliferation, invasion and resistance | Gooijer M.C. de, PhD | Beijnen J.H., prof. dr. | Tellingen O. van, dr. | Universiteit Utrecht (UU) | 2019 | Glioblastoma; Blood-brain barrier; Therapy development; Pharmacology; Cell biology; Combination therapy; Mouse models; | ||
Pharmacogenetics of sunitinib in metastatic renal cell carcinoma | Diekstra M.H.M., dr | Guchelaar H.J., prof. dr. | Swen J.J., PhD | Universiteit Leiden (UL) | 2017 | Genetics; Pharmacogenetics; Renal function; | ||
Patients at increased fracture risk : identification and pharmacological treatment | Klop C., PhD | Leufkens H.G.M., prof. dr. | Bijlsma J.W.J., prof. dr. | Vries F. de, prof. dr. | Welsing P.M.J., dr. | Universiteit Utrecht (UU) | 2016 | Fragility fracture; Hip fracture; Hip; Osteoporosis; Biphosphonate; Absolute risk prediction; FRAX; |
Methods for improving the safety of fluoropyrimidine anticancer drugs | Jacobs B.A.W., PhD | Schellens J.H.M., prof. dr. | Beijnen J.H., prof. dr. | Nuijen B., dr. | Universiteit Utrecht (UU) | 2016 | Fluoropyrimidines; Capecitabine; 5-fluorouracil; Dihydropyrimidine dehydrogenase; Thymidylate synthase; Safety; Phenotyping; Circadian rhythm; | |
Fluorescence-enhanced surgical navigation : towards tailored tumor detection | Boogerd L.S.F., PhD | Velde C.J.H. Van de, Prof.dr. | Burggraaf J., prof. dr. | Vahrmeijer A.L., Dr. | Universiteit Leiden (UL) | 2019 | Fluorescence guided surgery tailored tumor detection Intraoperative tumor imaging ICG CEA targeted tumor detection | |
Towards better fall prevention - examining the interplay between factors that influence gait in older patients | Groot M.H. de, PhD | Beijnen J.H., prof. dr. | Lamoth C.J.C., dr. | Universiteit Utrecht (UU) | 2017 | Falls; Gait analysis; Accelerometry; Frailty; Osteoporosis; Maturation; Medication use; Medication use; Geriatrics; Older patients; | ||
Determinants of treatment outcomes in epilepsy | Wassenaar M., PhD | Egberts A.C.G., prof. dr. | Leijten F.S.S., dr. | Uijl S.G., dr. | Universiteit Utrecht (UU) | 2014 | Epilepsy; Treatment; Treatment outcomes; Quality of life; Patient-perspectives; Clinical determinants; Seizures; Pharmacology; Daily practice; Community-based; | |
Sex hormones and cardiometabolic risk | Glisic M., PhD | Danser A.H.J., prof. dr. | Franco Duran O.H., Prof.dr. | Roks A.J.M., dr. | Erasmus Universiteit Rotterdam (EUR) | 2018 | Epidemiology; Pharmacology; Risk factors; Sex hormonesCardiovascular disease; Metabolism; | |
Predictive value of treatment quality indicators on outcomes in patients with diabetes | Sidorenkov G., PhD | Haaijer-Ruskamp F.M., prof. dr. | Zeeuw D. de, prof. dr. | Denig P., prof. dr. | Voorham J., dr. | Rijksuniversiteit Groningen (RUG) | 2013 | Endocrinology; Hemoglobine; Glycoproteins; Diabetes mellitus; Risk management; |
The quantification of growth hormone secretion : application of model-informed drug development in acromegaly | Esdonk M.J van | Graaf P.H., Prof.dr. | Burggraaf J., prof. dr. | Stevens J., Dr. | Universiteit Leiden (UL) | 2019 | Endocrinology Pulsatile profiles Population modelling Pharmacokinetic Pharmacodynamic modelling Clinical trial simulation | |
Multi dose drug dispensing for older patients in primary care | Mertens B.J., PhD | Bouvy M.L., prof. dr. | Marum R.J. van, prof. dr. | Kwint H.F., dr. | Universiteit Utrecht (UU) | 2019 | Elderly; Primary care; Multi-dose drug dispensing; | |
Medication optimisation : methodological aspects and new strategies | Mestres Gonzalvo C., PhD | Verhey F.R., prof.dr. | Kuy P.H.M. van der, dr. | Janknegt R., PharmD PhD | Universiteit Maastricht (UM) | 2018 | Elderly; Geriatrics; Hospital pharmacists; Medication use; Model-based; Model validation; Older patients; Optimal pharmacotherapy; Pharmaceutical care; Pharmacotherapy; Pharmacovigilance; | |
Drug-related problems: risk factors and the role of clinical pharmacists | Zaal R.J., PhD | Vulto A.G., prof. dr. | Haaijer-Ruskamp F.M., prof. dr. | Bemt P.M.L.A. van den, dr. | Erasmus Universiteit Rotterdam (EUR) | 2016 | Drug-related problems; Risk factors; |